- Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
Anastasiya Yakovenko et al, 2018, World Journal of Gastrointestinal Surgery CrossRef - Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer
Vijay Sagar Madamsetty et al, 2020, Cancers CrossRef - Combining Gemcitabine-Loaded Macrophage-like Nanoparticles and Erlotinib for Pancreatic Cancer Therapy
Hongqiao Cai et al, 2021, Molecular Pharmaceutics CrossRef - The Role of Genetics and Synergistic Effect of Targeting Common Genetic Mutations in Acute Lymphoblastic Leukemia (ALL)
Niloofar Pilehvari et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef - In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors
Cecilia Pesini et al, 2024, OncoImmunology CrossRef - The anti-dysenteric drug fraxetin enhances anti-tumor efficacy of gemcitabine and suppresses pancreatic cancer development by antagonizing STAT3 activation
Yangyang Guo et al, 2021, Aging CrossRef - JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens
Qian Hu et al, 2023, Frontiers in Bioengineering and Biotechnology CrossRef - Sodium cantharidinate, a novel anti-pancreatic cancer agent that activates functional p53
Xiaoxiao Liu et al, 2021, Science China Life Sciences CrossRef